Francis Jacob

📢 Exciting #PhD Opportunity in Carbohydrate Chemistry! Join our team @UniBasel to drive developments in glycan-based therapies 💊 🗓️Feb 2025 📍Switzerland 💼4-year funded 🔗Link below #GlycoTime #AcademicJobs @euroglyco @ozglyco @glyconet_nce @acs_carb @EuChemS @Glyco_Alps

Exciting news! The 7th issue of our DBM newsletter is here! We hope you enjoy reading it! 👇🏼👇🏼👇🏼 issuu.com/departementbio… #Newsletter #DBMBasel #departmentofbiomedicine #science #research #biomedicine

SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis biorxiv.org/cgi/content/sh… #biorxiv_cancer

@ArthurDondi Super exciting collaboration with many new ideas generated.

Delighted to present our full-length scRNA-seq study on ovarian cancer patients, in collaboration with the University Hospital Basel @labfranz ! nature.com/articles/s4146… Can we simultaneously detect isoform-level gene expression, mutations and gene fusions in cancer cells? 1/

Exciting time! Long-read scRNAseq unveils novel insights into ovarian cancer metastasis. We detected 52,000+ previously unreported isoforms, identified cell-specific changes, gene fusions, & confirmed mutations. nature.com/articles/s4146… #Genomics #ovariancancer

@CzerwinsMarcin @ElisaTelisa @IainWil92988866 Great conference, science and people. Thx to everyone

So when our conference came to a close, I would like to thank our keynote speakers: Elisa Fadda @ElisaTelisa, Francis Jacob @labfranz, Iain Wilson @IainWil92988866, Mariusz Olczak and Jolanta Łukasiewicz for memorable lectures. Great thanks to all other participants too!

Do not forget the deadline for #ESUR23 🔔! Looking forward to receiving your #UrologicalResearch abstracts and to welcoming you in Basel 🧫 🧬🔬

Pleased to share our review discussing the future of #prostatecancer patient-derived #xenografts published in @NatRevUrol . Great effort tackling this topic from Mitchell Lawrence, @ReneaTaylor1, and Gail Risbridger: nature.com/articles/s4158…

One week left to submit an application for our open 🌟 glycochemistry postdoc 🌟 positions! Interested candidates can apply via the UniBasel job portal link in the thread below #GlycoTime @euroglyco @InnoglyA @acs_carb @Glyco_Alps @glyconet_nce @GFRGlyco @glyco_pm @theNCFG

Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing for personalized oncology biorxiv.org/cgi/content/sh… #bioRxiv

Join our team!! Xmas came early in the form of a grant 😁 We are looking to fill TWO postdoc positions in chemoenzymatic and/or carbohydrate synthesis, with a focus on developing new glycan-based antimicrobial therapies. #GlycoTime #ChemPostdoc More info in thread 👇👇👇

Cancer cells use sugar molecules on their surface to disable attacks by the body’s immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized. @LImmunotherapy @DepBiomedicine @UniSpitalBasel unibas.ch/en/News-Events…

@DrRachelHevey @ElisaTelisa @euroglyco Let’s get in touch!

@labfranz @ElisaTelisa @euroglyco Yes, indeed! I actually saw the UniNews article about your recent Cell Reports paper and have been meaning to get in touch ... we are so close and I would love to connect in-person at some point! 😊

Making glycosylation "hot" for cancer immunotherapy: wonderful collaboration with Heinz Läubli @LImmunotherapy at @DepBiomedicine and @UniSpitalBasel science.org/doi/10.1126/sc… Much appreciated, thanks !

CRISPR-Cas9 approach for assessing genes predicting PARP inhibition published in @cddpress, nature.com/articles/s4141… Great team effort! Special thanks to @RicardoBouca, @DepBiomedicine and @UniSpitalBasel

Recent review together with Daniel Maslyar and Sam Nalle on Siglecs and sialic acids as target for cancer immunotherapy #glycotime #Immunotherapy Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches aacrjournals.org/cancerimmunolr…

If you are a scientist interested in glycobiology and cancer immunotherapy, please apply! jobs.unibas.ch/offene-stellen…

Registration now open for Glycobasque 5 18-19 November 2022, San Sebastian, Spain keynotes: Henrik Clausen, DK Geert-Jan Boons, NL, USA M.G. Finn, USA Sabine Flitsch, UK details: glycobasque.es